TLDR
- PayPal forecasted flat to slightly declining adjusted profit for 2026, sending shares lower, but recovery catalysts remain in play
- CVS Health reported $402.1 billion in full-year 2025 revenue and guided for at least $400 billion in 2026
- Nike reported $11.3 billion in Q3 2026 revenue with wholesale up 5% and North America showing growth
- HP posted Q1 2026 revenue of $14.4 billion, up 6.9% year over year, with free cash flow guidance of $2.8–$3.0 billion
- Estée Lauder shares dropped after fiscal 2026 guidance disappointed, even though profit beat expectations
PayPal, CVS Health, Nike, HP, and Estée Lauder are among the stocks drawing attention from investors looking for undervalued opportunities in 2026.
These are not simply cheap stocks. They share a common profile: cautious sentiment, but real business catalysts that could shift how Wall Street values them.
The Turnaround Stories
PayPal
PayPal is one of the clearest examples of low expectations meeting a possible recovery path. Reuters reported in February that the company forecasted flat to slightly declining adjusted profit for 2026, below Wall Street estimates.
The stock sold off sharply after leadership changes raised questions about execution. But if management improves branded checkout growth and expands Venmo monetization, the stock could start trading more like a recovering fintech platform.
CVS Health
CVS Health still looks inexpensive relative to the size of its business. The company reported full-year 2025 revenue of $402.1 billion. Management guided for 2026 adjusted EPS of $7.00 to $7.20, on revenue of at least $400 billion.
The stock does not need a full recovery to move higher. It only needs enough margin improvement in its insurance and pharmacy businesses for the market to treat it more like a durable cash-flow business.
Nike
Nike is still being treated by the market as a turnaround with too many moving parts. In fiscal Q3 2026 results released March 31, the company reported revenue of $11.3 billion and wholesale revenue up 5%. North America also grew.
Gross margin declined, and parts of the business remain under pressure. But some pieces are moving in the right direction, which is where undervalued setups often begin.
Cash Flow and Recovery Plays
HP
HP reported fiscal Q1 2026 revenue of $14.4 billion, up 6.9% year over year. Non-GAAP diluted EPS rose 9.5%, and free cash flow came in at $175 million. The company maintained its full-year free cash flow outlook of $2.8 billion to $3.0 billion.
The upside case rests on a steadier PC recovery and growing momentum in AI PCs. HP does not need dramatic revenue growth to move higher, just continued earnings resilience.
Estée Lauder
Estée Lauder is the highest-risk name on the list. Reuters reported in February that shares dropped after fiscal 2026 guidance disappointed, even though profit beat expectations.
Management said it was pushing a turnaround through product launches, marketing, and premium positioning. The market still sees weak U.S. demand, tariffs, and execution risk.
As of its most recent guidance, Estée Lauder has not yet shown consistent sales growth or margin recovery.
Final Thoughts
All five stocks share one thing in common. Sentiment is still cautious, but each has a real catalyst that could change how the market values it in 2026.
🚨 Our April Stock Picks Are Live!
A new month means new opportunities. Our analysts have just released their top stock picks for April, highlighting companies with strong momentum that rank highly on our KO Score algorithm. We’re also now sharing trade ideas for both long-term and short-term investors, giving you more ways to spot potential opportunities in the market.
Sign up to Knockout Stocks today and get 50% off to unlock the full list and see which stocks made the cut.
Use coupon code Special50 for your exclusive discount!







